These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11499724)

  • 1. Prevalence, characteristics and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation: insights from a study using a new implantable device.
    Israel CW; Ehrlich JR; Grönefeld G; Klesius A; Lawo T; Lemke B; Hohnloser SH
    J Am Coll Cardiol; 2001 Aug; 38(2):355-63. PubMed ID: 11499724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy.
    Israel CW; Hügl B; Unterberg C; Lawo T; Kennis I; Hettrick D; Hohnloser SH;
    J Cardiovasc Electrophysiol; 2001 Oct; 12(10):1121-8. PubMed ID: 11699520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of a prospective study of the clinical significance of atrial arrhythmias detected by implanted device diagnostics: the TRENDS study.
    Glotzer TV; Daoud EG; Wyse DG; Singer DE; Holbrook R; Pruett K; Smith K; Hilker CE
    J Interv Card Electrophysiol; 2006 Jan; 15(1):9-14. PubMed ID: 16680544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator.
    Gillis AM; Unterberg-Buchwald C; Schmidinger H; Massimo S; Wolfe K; Kavaney DJ; Otterness MF; Hohnloser SH;
    J Am Coll Cardiol; 2002 Nov; 40(9):1653-9. PubMed ID: 12427419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Device treatment of atrial tachycardia--minor additional effect of repeating pacing sequences.
    Schuster P; Faerestrand S; Ohm OJ
    Int J Cardiol; 2005 Sep; 104(1):10-4. PubMed ID: 16137503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High atrial antitachycardia pacing therapy efficacy is associated with a reduction in atrial tachyarrhythmia burden in a subset of patients with sinus node dysfunction and paroxysmal atrial fibrillation.
    Gillis AM; Koehler J; Morck M; Mehra R; Hettrick DA
    Heart Rhythm; 2005 Aug; 2(8):791-6. PubMed ID: 16051111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias.
    Lee MA; Weachter R; Pollak S; Kremers MS; Naik AM; Silverman R; Tuzi J; Wang W; Johnson LJ; Euler DE;
    J Am Coll Cardiol; 2003 Jun; 41(11):1926-32. PubMed ID: 12798559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled study on the effect of verapamil on atrial tachycaarrhythmias in patients with brady-tachy syndrome implanted with a DDDR pacemaker.
    Boriani G; Bertaglia E; Carboni A; Latini R; Biffi M; Martignani C; Sciotto F; Branzi A
    Int J Cardiol; 2005 Sep; 104(1):73-6. PubMed ID: 16137513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator.
    Adler SW; Wolpert C; Warman EN; Musley SK; Koehler JL; Euler DE
    Circulation; 2001 Aug; 104(8):887-92. PubMed ID: 11514374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes.
    Swiryn S; Orlov MV; Benditt DG; DiMarco JP; Lloyd-Jones DM; Karst E; Qu F; Slawsky MT; Turkel M; Waldo AL;
    Circulation; 2016 Oct; 134(16):1130-1140. PubMed ID: 27754946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of rapid atrial pacing for termination of drug refractory atrial fibrillation: results of a dual chamber implantable cardioverter defibrillator trial.
    Gold MR; Leman RB; Euler DE
    Card Electrophysiol Rev; 2003 Dec; 7(4):341-4. PubMed ID: 15071249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive atrial-based antitachycardia pacing therapy reduces atrial tachyarrhythmias.
    Crossley GH; Padeletti L; Zweibel S; Hudnall JH; Zhang Y; Boriani G
    Pacing Clin Electrophysiol; 2019 Jul; 42(7):970-979. PubMed ID: 30977146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable dual-chamber defibrillator for the selective treatment of spontaneous atrial and ventricular arrhythmias: arrhythmia incidence and device performance.
    Schuchert A; Boriani G; Wollmann C; Biffi M; Kühl M; Sperzel J; Stiller S; Gasparini G; Böcker D
    J Interv Card Electrophysiol; 2005 Mar; 12(2):149-56. PubMed ID: 15744468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failed anti-tachycardia pacing can be used to differentiate atrial arrhythmias from ventricular tachycardia in implantable cardioverter-defibrillators.
    Michael KA; Enriquez A; Baranchuk A; Haley C; Caldwell J; Simpson CS; Abdollah H; Redfearn DP
    Europace; 2015 Jan; 17(1):78-83. PubMed ID: 25031236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial.
    Padeletti L; Pürerfellner H; Mont L; Tukkie R; Manolis AS; Ricci R; Inama G; Serra P; Scheffer MG; Martins V; Warman EN; Vimercati M; Grammatico A; Boriani G;
    Heart Rhythm; 2015 Aug; 12(8):1717-25. PubMed ID: 25869753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial pacing therapies for prevention of atrial fibrillation in patients with implantable defibrillators.
    Gillis AM
    Card Electrophysiol Rev; 2003 Dec; 7(4):345-7. PubMed ID: 15071250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
    Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
    Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verification of pacemaker automatic mode switching for the detection of atrial fibrillation and atrial tachycardia with Holter recording.
    de Voogt WG; van Hemel NM; van de Bos AA; Koïstinen J; Fast JH
    Europace; 2006 Nov; 8(11):950-61. PubMed ID: 17043069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias.
    Ricci R; Pignalberi C; Disertori M; Capucci A; Padeletti L; Botto G; Toscano S; Miraglia F; Grammatico A; Santini M
    Eur Heart J; 2002 Sep; 23(18):1471-9. PubMed ID: 12208228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incremental programming of atrial anti-tachycardia pacing therapies in bradycardia-indicated patients: effects on therapy efficacy and atrial tachyarrhythmia burden.
    Hügl B; Israel CW; Unterberg C; Lawo T; Geller JC; Kennis IM; Euler DE; Koehler JL; Hettrick DA;
    Europace; 2003 Oct; 5(4):403-9. PubMed ID: 14753639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.